Income statement
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 18M | 19M | 22M | 16M | 12M |
| Gross Profit | 7M | 7M | 9M | 6M | 4M |
| Operating Income | -2M | -46K | 2M | 2M | -9K |
| EBITDA | -2M | 153K | 3M | 2M | 234K |
| Net Income | -3M | -912K | 1M | 899K | -770K |
| EPS (Diluted) | β | β | β | β | β |
Consumer Cyclical
Live Price
Offline$0.0114
+14.00% today
1Y Change
+14.00%
Window
Jun 23, 2025 β Jun 17, 2026
Coverage: 248 bars Β· Jun 23, 2025 β Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Phoenix Footwear Group, Inc. (PXFG) is a Consumer Cyclical stock with listed on OTC. The stock last traded around $0.01 and up 14.0% across the available one-year price window (Jun 23, 2025 β Jun 17, 2026). Baseline metrics include revenue growth of -6.1%, EPS growth of -179.9%, a dividend yield of 0.0%. What stands out right now is revenue -6.1%, EPS -179.9%, free cash flow -129.2% with operating margin -9.0% and ROIC -18.3%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines PXFG price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Cyclical peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PXFG
β
Normalized return
SPY
β
S&P 500
Excess Return
β
Relative to SPY
PXFG Max Drawdown
-50.00%
Trailing 1Y
SPY Max Drawdown
β
Trailing 1Y
Uses the longest available daily history for PXFG and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$12.3M
-24.2% YoY
FY Net Income
-$770.0K
-185.7% YoY
Free Cash Flow
$522.0K
-20.4% YoY
Revenue Growth
-6.1%
EPS Growth
-179.9%
Gross Margin
36.7%
Net Margin
-14.9%
Income statement
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 18M | 19M | 22M | 16M | 12M |
| Gross Profit | 7M | 7M | 9M | 6M | 4M |
| Operating Income | -2M | -46K | 2M | 2M | -9K |
| EBITDA | -2M | 153K | 3M | 2M | 234K |
| Net Income | -3M | -912K | 1M | 899K | -770K |
| EPS (Diluted) | β | β | β | β | β |
Balance sheet
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Cash & Equivalents | 14K | 37K | 9K | 45K | 12K |
| Total Assets | 13M | 15M | 18M | 11M | 11M |
| Total Liabilities | 14M | 13M | 15M | 10M | 11M |
| Shareholder Equity | -843K | 2M | 3M | 1M | 189K |
| Total Debt | 10M | 8M | 10M | 6M | 7M |
| Net Debt | 10M | 8M | 10M | 6M | 7M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
549K
-16.3% YoY
Capital Expenditures
27K
Free Cash Flow
522K
-20.4% YoY
Key ratios
Gross Margin
36.7%
Operating Margin
-9.0%
Net Margin
-14.9%
ROE
-541.4%
Debt / Equity
-11.53x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.